UBS Group’s Ariad Pharmaceuticals Inc ARIA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-370,402
| Closed | -$4.61M | – | 7117 |
|
|
2016
Q4 | $4.61M | Buy |
370,402
+98,160
| +36% | +$1.22M | ﹤0.01% | 1656 |
|
|
2016
Q3 | $3.73M | Buy |
272,242
+64,066
| +31% | +$877K | ﹤0.01% | 1764 |
|
|
2016
Q2 | $1.54M | Buy |
208,176
+82,531
| +66% | +$610K | ﹤0.01% | 2388 |
|
|
2016
Q1 | $803K | Sell |
125,645
-378,818
| -75% | -$2.42M | ﹤0.01% | 2810 |
|
|
2015
Q4 | $3.15M | Buy |
504,463
+272,865
| +118% | +$1.71M | ﹤0.01% | 1850 |
|
|
2015
Q3 | $1.35M | Sell |
231,598
-19,604
| -8% | -$115K | ﹤0.01% | 2431 |
|
|
2015
Q2 | $2.08M | Buy |
251,202
+27,481
| +12% | +$227K | ﹤0.01% | 2275 |
|
|
2015
Q1 | $1.84M | Sell |
223,721
-22,887
| -9% | -$189K | ﹤0.01% | 2352 |
|
|
2014
Q4 | $1.7M | Buy |
+246,608
| New | +$1.7M | ﹤0.01% | 2363 |
|